Attenuation of human herpesvirus 6B reactivation by aging

Objective There has been little research on human herpesvirus 6B (HHV‐6B) in healthy adults and prevalences in different age groups have been unclear. Therefore, the major objective of this study was to evaluate seroprevalence to HHV‐6 antibodies in ordinary working people and examine the effect of...

Full description

Saved in:
Bibliographic Details
Published inJournal of medical virology Vol. 91; no. 7; pp. 1335 - 1341
Main Authors Kobayashi, Nobuyuki, Nishiyama, Toshiko, Yamauchi, Takashi, Shimada, Kazuya, Suka, Machi, Kondo, Kazuhiro, Yanagisawa, Hiroyuki
Format Journal Article
LanguageEnglish
Published United States Wiley Subscription Services, Inc 01.07.2019
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Objective There has been little research on human herpesvirus 6B (HHV‐6B) in healthy adults and prevalences in different age groups have been unclear. Therefore, the major objective of this study was to evaluate seroprevalence to HHV‐6 antibodies in ordinary working people and examine the effect of aging on seroprevalence. Also, as HHV‐6B is reactivated in saliva, another objective was to investigate an association between age and HHV‐6B reactivation based on measured salivary HHV‐6 DNA levels. Methods Our subjects were 77 ordinary office workers who underwent a health checkup. In this population, we measured anti‐HHV‐6 antibody titers using enzyme‐linked immunosorbent assay and salivary HHV‐6 DNA levels. In addition to examining an association with age, we examined associations with body mass index, smoking habit, and alcohol consumption as confounding factors. Results There was a significant decrease in the seropositivity of HHV‐6 antibodies in subjects of 50 years and older, and age was significantly negatively correlated with anti‐HHV‐6 antibody titers. Age and salivary HHV‐6 DNA levels were also significantly negatively correlated but there were no significant correlations with other factors. Conclusions Our results suggest that HHV‐6B reactivation is attenuated by aging. Thus, HHV‐6 antibodies steadily decrease in the body with aging.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ISSN:0146-6615
1096-9071
1096-9071
DOI:10.1002/jmv.25434